Maximize merger arbitrage growth returns

Out maneuver the market and identify potential regulatory hurdles for mergers and acquisitions with MLex. Our exclusive market insight, analysis and commentary covers deals from pre-notification through notification, review and approval.

The world's leading hedge funds use the MLex DealRisk service to analyze deals through notification, review, approval and compliance with daily case updates on M&A clearance.

Gain perspective on global activist situations

Our Activist coverage seeks to put some of the world’s most significant activist situations into perspective, allowing investors to put breaking news on activist shareholdings into context and inform their decision-making.

Our journalists on the ground will join the dots on latest developments, providing background and insight on investor profiles and possible intent.

As reported first by MLex

Like to read the full text of these, or any other MLex insights? Request a trial subscription via the form at the bottom of the page.

Energizer set to win conditional EU approval for Spectrum Brands deal

7 December 2018

​Alstom-Siemens deal to get recommendation of approval with remedies in Brazil

4 December 2018

IBM-Red Hat deal review disputed by DOJ, FTC

3 December 2018

Knauf, USG deal's impact on competition to be weakened by strong Chinese competitor

21 November 2018

Disney's Fox deal expected to secure EU approval

2 November 2018

Microsoft-GitHub deal cleared by DOJ

26 September 2018

​Suzano-Fibria deal set for unconditional approval in Brazil

21 September 2018

Tronox, Cristal on track to win conditional EU approval

15 June 2018

KLA-Tencor, Orbotech file for South Korean merger clearance

14 June 2018

Linde-Praxair deal set for Brazilian clearance next week

7 June 2018

Northrop Grumman’s acquisition of Orbital ATK could receive US antitrust approval by mid-June

25 May 2018

Bayer-Monsanto deal hasn't received staff recommendation at US DOJ; decision expected by early April

2 March 18

Qualcomm still to refile NXP deal to China’s Mofcom as deadline looms

12 April 2018

Tronox, Cristal point to Chinese competition in EU hearing on titanium-dioxide deal

11 April 2018

Myer's board, management should remain, investor Wilson Asset Management says

19 September 2018

Suzano-Fibria deal set for unconditional approval in Brazil

21 September 2018

Review and learn from past merger decisions, EU Commission's chief economist urges

1 October 2018

Key Deals

Our coverage includes exclusive insight and analysis on the following key deals around the globe.


United States of America

AT&T/Time Warner
Illumina/Pacific Biosciences
IBM/Red Hat
Bristol-Myers Squibb/Celgene
Fidelity National Financial/Stewart Information Services


The EU & UK

Illumina/Pacific Biosciences
IBM/Red Hat
Bristol-Myers Squibb/Celgene



Bristol-Myers Squibb/Celgene

Latin America

Latin America

Disney/21st Century Fox

Request a Free Trial

MLex takes your privacy seriously and we will only use your personal information to provide you with relevant material. By submitting your details you are agreeing to our Terms and Conditions, our Privacy Policy and our Cookie Policy. We will not share your personal information with any 3rd parties.

However, as we believe that you may also have an interest in receiving information about similar products and services in the future we may from time to time contact you about related products. You can choose not to be contacted and manage your communications from MLex in our Preference Center

You can also phone us on:

UK (Toll Free) +44 800 999 3237
US (Toll Free) +1 800 356 6547
Hong Kong +852 2965 1424